Showing results (101-110 of 170) with videos related to
Sort By:
Pageof 17
Transfusion Medicine (Oxford, England)|February 20, 2002
Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplantC W Tiplady, J M Fitzgerald, G H Jackson, et al.Clinical Immunology and Immunopathology|October 1, 1988
Suppression of human granulocyte-macrophage colony formation in vitro by natural killer cellsA M Dickinson, E A Jacobs, I K Williamson, et al.BMJ (Clinical Research Ed.)|February 22, 1992
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal diseaseM E Stevens, G P Summerfield, A A Hall, et al.British Journal of Haematology|June 1, 1994
Relapse of acute lymphoblastic leukaemia 14 years after presentation: use of molecular techniques to confirm true re-emergenceM Levasseur, Z T Maung, G H Jackson, et al.Leukemia|September 1, 1994
Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukemiaZ T Maung, L Hogarth, M M Reid, et al.Leukemia|February 1, 1995
De novo acute myeloid leukaemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Northern Region Haematology GroupP R Taylor, M M Reid, A N Stark, et al.British Journal of Haematology|September 1, 1995
Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemiaZ T Maung, M M Reid, E Matheson, et al.Leukemia & Lymphoma|January 1, 1992
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working PartyS J Proctor, P Taylor, M J Mackie, et al.Bone Marrow Transplantation|December 1, 1994
High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working PartyJ W Sweetenham, R Pearce, T Philip, et al.Bone Marrow Transplantation|December 1, 1991
Supernatant cell counts from long-term bone marrow culture correlate with the speed of engraftment following autologous bone marrow transplantationG H Jackson, A J Clarke, P Taylor, et al.Pageof 17